Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Melatonin for Propofol Reduction in Subdural Hematoma Evacuation
NCT03732963Phase 1Completed
- Sponsor
- Cairo University
- Start
- Sep 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial in chronic subdural hematoma (CSDH) comparing Melatonin Group with Placebo Group (2 arms). Primary endpoint: Propofol consumption. Started Sep 2018; status: completed.
02
Drugs
melatonin
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT03732963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03732963.